Skip to content

13F-HR filed by Avidity Partners Management LP

Avidity Partners Management LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 56 holding rows worth $501,976,646.

Accession
0001791827-25-000007
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 56 entries on the cover page, a total value of $501,976,646 stated on the cover page (in dollars after the unit check, H1), rows summing to $501,976,646 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CG ONCOLOGY INC156944100COMMON STOCK1,499,942$38,998,492dollars as filed
Boston Scientific Corporation101137107COM321,800$34,564,538dollars as filed
NATERA INC COM632307104Stock199,300$33,669,742dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM1,742,902$32,470,264dollars as filed
EXACT SCIENCES CORP COM30063P105Stock355,000$18,864,700dollars as filed
TENET HEALTHCARE CORP COM NEW88033G407Stock106,000$18,656,000dollars as filed
DEXCOM INC COM252131107Stock210,500$18,374,545dollars as filed
Danaher Corporation235851102COM89,700$17,719,338dollars as filed
HINGE HEALTH INC A433313103COMMON STOCK322,344$16,681,302dollars as filed
Intuitive Surgical,Inc.46120E602COM27,100$14,726,411dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share650,000$13,429,000dollars as filed
REPLIGEN CORP COM759916109Stock106,500$13,246,470dollars as filed
Thermo Fisher Scientific Inc.883556102COM29,600$12,001,616dollars as filed
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR689,500$11,556,020dollars as filed
JADE BIOSCIENCES INC008064206COM NEW1,127,186$11,260,588dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK1,064,500$10,208,555dollars as filed
UnitedHealth Group Inc91324P102COM32,000$9,983,040dollars as filed
MCKESSON CORP COM58155Q103Stock13,500$9,892,530dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock94,500$9,864,855dollars as filed
CENCORA INC COM03073E105Stock32,800$9,835,080dollars as filed
HEALTHEQUITY INC COM42226A107Stock92,000$9,637,920dollars as filed
ENCOMPASS HEALTH CORP COM29261A100Stock74,000$9,074,620dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock228,600$8,410,194dollars as filed
AKERO THERAPEUTICS INC00973Y108COM134,000$7,150,240dollars as filed
OMADA HEALTH INC68170A108COM390,600$7,147,980dollars as filed
BEAM THERAPEUTICS INC07373V105COM409,400$6,963,894dollars as filed
HUMANA INC COM444859102Stock27,600$6,747,648dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V302COMMON STOCK1,858,596$6,393,570dollars as filed
ORGANON & CO COMMON STOCK68622V106Stock640,000$6,195,200dollars as filed
BRIDGEBIO PHARMA INC10806X102COM140,000$6,045,200dollars as filed
INSMED INC COM PAR $.01457669307Stock59,000$5,937,760dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock19,000$5,750,160dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM154,000$5,599,440dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM7,477,255$4,899,097dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock352,124$3,947,310dollars as filed
IMMUNIC INC4525EP101COM5,615,811$3,917,028dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM268,000$3,757,360dollars as filed
DOXIMITY INC CL A26622P107Stock60,000$3,680,400dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock107,891$3,376,988dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS33,800$3,196,804dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM340,000$3,184,100dollars as filedcall
UNIQURE NVN90064101SHS207,000$2,885,580dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock65,000$2,822,950dollars as filed
SOLENO THERAPEUTICS INC834203309COM32,000$2,680,960dollars as filed
CARDINAL HEALTH INC14149Y108COM15,000$2,520,000dollars as filed
ARS PHARMACEUTICALS INC82835W108COM140,000$2,443,000dollars as filed
KEZAR LIFE SCIENCES INC49372L209COM NEW502,600$2,301,908dollars as filed
INTELLIA THERAPEUTICS INC45826J105COM232,000$2,176,160dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock39,000$1,840,800dollars as filed
ARVINAS INC04335A105COM243,162$1,789,672dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM150,000$1,404,750dollars as filed
SCYNEXIS INC811292200COM NEW1,228,910$829,268dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK134,566$579,979dollars as filed
ALTIMMUNE INC02155H200COM NEW105,000$406,350dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock11,300$226,678dollars as filed
Reviva Pharmaceuticals Holdings Inc76152G100Common Stock138,000$52,592dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001791827-25-000007this filing2025-08-14acceptance time not in the bulk data set